Correlation Between VentriPoint Diagnostics and MedMira

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and MedMira at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and MedMira into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VentriPoint Diagnostics and MedMira, you can compare the effects of market volatilities on VentriPoint Diagnostics and MedMira and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of MedMira. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and MedMira.

Diversification Opportunities for VentriPoint Diagnostics and MedMira

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between VentriPoint and MedMira is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and MedMira in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MedMira and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with MedMira. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MedMira has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and MedMira go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and MedMira

Assuming the 90 days horizon VentriPoint Diagnostics is expected to generate 141.5 times less return on investment than MedMira. But when comparing it to its historical volatility, VentriPoint Diagnostics is 1.12 times less risky than MedMira. It trades about 0.0 of its potential returns per unit of risk. MedMira is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  7.00  in MedMira on August 30, 2024 and sell it today you would earn a total of  1.00  from holding MedMira or generate 14.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

VentriPoint Diagnostics  vs.  MedMira

 Performance 
       Timeline  
VentriPoint Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
MedMira 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MedMira has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, MedMira is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

VentriPoint Diagnostics and MedMira Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VentriPoint Diagnostics and MedMira

The main advantage of trading using opposite VentriPoint Diagnostics and MedMira positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, MedMira can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedMira will offset losses from the drop in MedMira's long position.
The idea behind VentriPoint Diagnostics and MedMira pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities